Acquisition · Healthcare & Life Sciences

Redcliffe Labs acquires Megavision Diagnostics for ₹40 crore

By Startup Enthusiast · 11 August 2026

What they do

Redcliffe Labs is an omnichannel diagnostic service provider headquartered in Noida

It acquired Pune-based Megavision Diagnostics Center for approximately ₹40 crore, adding two MRI-equipped centres

The acquisition is part of Redcliffe's strategy to expand integrated diagnostics across Western India

Redcliffe Labs has acquired Megavision Diagnostics Center in Pune for approximately ₹40 crore.
Megavision runs two MRI-equipped centres in Pune's Pimpri-Chinchwad area and has served the region for over two decades.
The acquisition adds advanced imaging (MRI) capabilities to Redcliffe's pathology network.
Redcliffe retains Megavision's entire workforce.
Founder and director Dr Kedar Prabhakar Bhate continues to lead the business as Megavision Redcliffe Labs.
Dr Bhate will work with Redcliffe's Clinical Board to strengthen radiology services.
Redcliffe did not disclose the purchase price in its formal announcement.

The acquisition comes amid consolidation in India's diagnostics sector in 2026.
In May 2026, Dr Lal PathLabs acquired Shahbazkers Diagnostic Centre for up to ₹20 crore.
Also in May 2026, MedGenome acquired a majority stake in Siddhi Diagnostics & Research Centre.
Neuberg Diagnostics acquired a controlling stake in NM Medical (18 centres across Mumbai, Pune, Bengaluru).
Diagnostic players are moving towards integrated platforms combining pathology, radiology, imaging, genomics, and preventive healthcare.

Redcliffe Labs is an omnichannel diagnostic service provider headquartered in Noida.
It offers pathology, radiology, imaging, genomics (GeneCliffe), and preventive healthcare packages.
Redcliffe provides home sample collection, temperature-controlled sample transport, and doctor-verified smart reports.
It has a she-centric diagnostic platform called Femcliffe.
Redcliffe has served more than 1 crore customers to date.
It operates across more than 220 cities with over 80 owned laboratories.
Its network covers more than 4,000 pincodes and offers more than 3,600 diagnostic tests.
Redcliffe has 1,500+ trained phlebotomists and 2,000+ collection centres.

Redcliffe plans to use partnerships and acquisitions to expand further across Western India.
The acquisition is part of Redcliffe's strategy to expand integrated diagnostics across Western India.